GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Matinas BioPharma Holdings Inc (FRA:6LJ0) » Definitions » Common Stock

Matinas BioPharma Holdings (FRA:6LJ0) Common Stock : €0.00 Mil (As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Matinas BioPharma Holdings Common Stock?

Matinas BioPharma Holdings's quarterly common stock increased from Mar. 2024 (€0.02 Mil) to Jun. 2024 (€0.02 Mil) but then declined from Jun. 2024 (€0.02 Mil) to Sep. 2024 (€0.00 Mil).

Matinas BioPharma Holdings's annual common stock increased from Dec. 2021 (€0.02 Mil) to Dec. 2022 (€0.02 Mil) but then declined from Dec. 2022 (€0.02 Mil) to Dec. 2023 (€0.02 Mil).


Matinas BioPharma Holdings Common Stock Historical Data

The historical data trend for Matinas BioPharma Holdings's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Matinas BioPharma Holdings Common Stock Chart

Matinas BioPharma Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 0.02 0.02 0.02 0.02

Matinas BioPharma Holdings Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.02 0.02 0.02 -

Matinas BioPharma Holdings Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Matinas BioPharma Holdings Business Description

Traded in Other Exchanges
Address
1545 Route 206 South, Suite 302, Bedminster, NJ, USA, 07921
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.

Matinas BioPharma Holdings Headlines

No Headlines